IONS

#661
Ionis Pharmaceuticals, Inc. Common Stock
81.1500
+2.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
81.1200
81.1500
Intervallo Annuale
66.6600
86.7400
Variazione giornaliera
+2.42%
Variazione Mensile
-1.23%
Variazione di 6 mesi
+12.51%
Variazione Annuale
+12.51%
Chiusura Precedente
79.2300
Open
81.1200
Bid
Ask
Low
81.1200
High
81.1500
Volume
171
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
  • Market Capitalization 12.914 B
  • Employee 927
  • Founded 1989
  • CEO Brett P. Monia Ph.D.
  • Website www.ionis.com
  • Headquarter California, United States
  • FIGI BBG000JH6683
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-20.07
Price to sales ratio
11.27
Dividends per share
—
Dividend yield %
—

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.

Notizie